Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...
GRAIL is the only company that has applied for MCED FDA premarket approval so far; if approved by the FDA and covered by ...
Carol Johnson is one of 120 property owners in western Niagara County who received a letter from the New York State DEC and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果